
Log in to your Inderes Free account to see all free content on this page.
Revenio Group
30.56
EUR
+1.19 %
Corporate customer
REG1V
NASDAQ Helsinki
Medical Equipment & Services
Health Care
14,060 following
+1.19%
+12.44%
+14.97%
+7.45%
+10.56%
+20.79%
-33.54%
+4.84%
+1,508.42%
Revenio is a medical technology company. Within the Group, there is research and development of pressure measurement technology that is used in the treatment of a number of diseases such as glaucoma, osteoporosis, skin cancer, and asthma. Operations are held worldwide and are run via most subsidiaries, each with a business focus. The company's head office is located in Vantaa.
Read moreMarket cap
815.37M EUR
Turnover
226.25K EUR
P/E (adj.) (24e)
EV/EBIT (adj.) (24e)
P/B (24e)
EV/S (24e)
Dividend yield-% (24e)
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
13.2.
2025
Annual report '24
10.4.
2025
General meeting '25
29.4.
2025
Interim report Q1'25
Risk
Business risk
Valuation risk
Low
High
ShowingAll content types

Revenio Group’s Financial statement release 2024 will be published on February 13, 2025
Revenio Extensive Report: The future looks bright
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
iCare MAIA: A new level of excellence in microperimetry

Life Science Companies as Investments | Life Science Night Dec. 2, 2024
Revenio Q3'24: Slight increase in cost structure

Revenio Interim Report Q3/2024
Revenio Group Corporation’s financial reporting and Annual General Meeting in 2025
Revenio Group Corporation: Interim report January 1 - September 30, 2024
Modular Finance IR Consensus: Revenio Group – Consensus estimates Q3 2024

Revenio Q3'24 preview: Interesting quarter behind
Invitation to Revenio Group’s audiocast and teleconference call

Value Creators: Revenio
Revenio’s Icare launched slit lamp tonometer
Revenio Group’s subsidiary Icare launches slit lamp tonometer
Revenio acquires Dutch AI software company Thirona Retina
Revenio Group invests in artificial intelligence by acquiring AI software company Thirona Retina from Dutch company Thirona
Revenio Group Corporation: Managers' Transactions – Kate Taylor
Revenio Q2'24: Company progress on track
